A

Acumen Pharmaceuticals
D

ABOS

2.70000
USD
0.19
(7.36%)
مغلق
حجم التداول
23,626
الربح لكل سهم
-2
العائد الربحي
-
P/E
-1
حجم السوق
194,974,447
المقالات
المزيد

العنوان: Acumen Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, isa subclass monoclonal antibody that selectively targets amyloid-beta oligomers. The product pipelines include: ALTITUDE-AD; and INTERCEPT-AD.